APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $364,127 | +51.2% | 3,997 | +9.5% | 0.01% | +66.7% |
| Q1 2023 | $240,754 | +1.2% | 3,650 | -30.6% | 0.00% | -40.0% |
| Q2 2022 | $238,000 | -91.1% | 5,259 | -90.1% | 0.01% | -84.4% |
| Q1 2022 | $2,688,000 | -32.7% | 52,899 | -37.4% | 0.03% | +10.3% |
| Q4 2021 | $3,995,000 | +224.5% | 84,493 | +333.8% | 0.03% | +163.6% |
| Q2 2021 | $1,231,000 | +103.5% | 19,477 | +38.1% | 0.01% | +57.1% |
| Q1 2021 | $605,000 | -81.3% | 14,102 | -85.8% | 0.01% | -93.4% |
| Q2 2020 | $3,235,000 | +191.7% | 99,045 | +139.3% | 0.11% | +140.9% |
| Q1 2020 | $1,109,000 | -51.0% | 41,389 | -44.0% | 0.04% | +7.3% |
| Q4 2019 | $2,263,000 | – | 73,883 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |